Memo Therapeutics
Series CMemo Therapeutics raised €20M in a Series C round in May 2024. The company is based in Zurich, Switzerland. Investors in the round: Kurma Partners, Ysios Capital. Data as of 4 Nov 2026.
Amount raised
€20M
€20,470,829
Native amount
20,000,000 CHF
Stage
Series C
series c
Investors
2
Provenance & confidence
High confidenceAmount
20,000,000 CHF
ECB-at-date → €20M · rate 0.977 on 2024-05-07
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
May 2024
Round type
series c
Amount (EUR)
€20M